140 related articles for article (PubMed ID: 24770890)
1. [Near fatal intoxication with the novel psychoactive substance 25C-NBOMe].
Grautoff S; Kähler J
Med Klin Intensivmed Notfmed; 2014 May; 109(4):271-5. PubMed ID: 24770890
[TBL] [Abstract][Full Text] [Related]
2. A fatal poisoning involving 25C-NBOMe.
Andreasen MF; Telving R; Rosendal I; Eg MB; Hasselstrøm JB; Andersen LV
Forensic Sci Int; 2015 Jun; 251():e1-8. PubMed ID: 25841303
[TBL] [Abstract][Full Text] [Related]
3. [Fatal intoxication with the new designer drug 25C-NBOMe].
Tarpgaard M; Mærkedahl R; Lauridsen KB
Ugeskr Laeger; 2015 Aug; 177(35):. PubMed ID: 26324189
[TBL] [Abstract][Full Text] [Related]
4. Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MS
Caspar AT; Brandt SD; Stoever AE; Meyer MR; Maurer HH
J Pharm Biomed Anal; 2017 Feb; 134():158-169. PubMed ID: 27915193
[TBL] [Abstract][Full Text] [Related]
5. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
Stellpflug SJ; Kealey SE; Hegarty CB; Janis GC
J Med Toxicol; 2014 Mar; 10(1):45-50. PubMed ID: 23872917
[TBL] [Abstract][Full Text] [Related]
6. Drug Recognition Evaluation and Chemical Confirmation of a 25C-NBOMe-Impaired Driver.
Rajotte JW; Palmentier JFP; Wallage HR
J Forensic Sci; 2017 Sep; 62(5):1410-1413. PubMed ID: 28261791
[TBL] [Abstract][Full Text] [Related]
7. Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature.
Suzuki J; Dekker MA; Valenti ES; Arbelo Cruz FA; Correa AM; Poklis JL; Poklis A
Psychosomatics; 2015; 56(2):129-39. PubMed ID: 25659919
[TBL] [Abstract][Full Text] [Related]
8. Detection of 25C-NBOMe in Three Related Cases.
Kristofic JJ; Chmiel JD; Jackson GF; Vorce SP; Holler JM; Robinson SL; Bosy TZ
J Anal Toxicol; 2016 Jul; 40(6):466-72. PubMed ID: 27206645
[TBL] [Abstract][Full Text] [Related]
9. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.
Tang MH; Ching CK; Tsui MS; Chu FK; Mak TW
Clin Toxicol (Phila); 2014 Jun; 52(5):561-5. PubMed ID: 24779864
[TBL] [Abstract][Full Text] [Related]
10. Pathological findings in 2 cases of fatal 25I-NBOMe toxicity.
Walterscheid JP; Phillips GT; Lopez AE; Gonsoulin ML; Chen HH; Sanchez LA
Am J Forensic Med Pathol; 2014 Mar; 35(1):20-5. PubMed ID: 24457586
[TBL] [Abstract][Full Text] [Related]
11. Zebrafish and
Álvarez-Alarcón N; Osorio-Méndez JJ; Ayala-Fajardo A; Garzón-Méndez WF; Garavito-Aguilar ZV
Toxicol Rep; 2021; 8():315-323. PubMed ID: 33598409
[TBL] [Abstract][Full Text] [Related]
12. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
Gatch MB; Dolan SB; Forster MJ
Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
[TBL] [Abstract][Full Text] [Related]
13. Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMe.
Gerostamoulos D; Glowacki L; Pricone M; Crump K; Di Rago M; Joubert S; Lynch MJ; Woodford NW; Drummer OH
J Anal Toxicol; 2023 Mar; 47(2):191-196. PubMed ID: 35975553
[TBL] [Abstract][Full Text] [Related]
14. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
[TBL] [Abstract][Full Text] [Related]
15. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.
Kamińska K; Świt P; Malek K
J Anal Toxicol; 2021 Jan; 44(9):947-956. PubMed ID: 32128596
[TBL] [Abstract][Full Text] [Related]
16. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
Poklis JL; Raso SA; Alford KN; Poklis A; Peace MR
J Anal Toxicol; 2015 Oct; 39(8):617-23. PubMed ID: 26378135
[TBL] [Abstract][Full Text] [Related]
17. 2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine (25D-NBOMe) and N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) induce adverse cardiac effects in vitro and in vivo.
Yoon KS; Yun J; Kim YH; Shin J; Kim SJ; Seo JW; Hyun SA; Suh SK; Cha HJ
Toxicol Lett; 2019 Apr; 304():50-57. PubMed ID: 30658151
[TBL] [Abstract][Full Text] [Related]
18. Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.
Laskowski LK; Elbakoush F; Calvo J; Exantus-Bernard G; Fong J; Poklis JL; Poklis A; Nelson LS
J Med Toxicol; 2015 Jun; 11(2):237-41. PubMed ID: 25387562
[TBL] [Abstract][Full Text] [Related]
19. Death after 25C-NBOMe and 25H-NBOMe consumption.
Morini L; Bernini M; Vezzoli S; Restori M; Moretti M; Crenna S; Papa P; Locatelli C; Osculati AMM; Vignali C; Groppi A
Forensic Sci Int; 2017 Oct; 279():e1-e6. PubMed ID: 28893436
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
Wood DM; Sedefov R; Cunningham A; Dargan PI
Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
